MedPath

In patients undergoing brain tumour surgery , retina thickness is assessed for comparison of vision before and after surgery

Not Applicable
Conditions
Health Condition 1: D330- Benign neoplasm of brain, supratentorial
Registration Number
CTRI/2023/04/051238
Lead Sponsor
Dr Arla Sai Varsha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age more than 18 years, both males and females

- All cases of Pituitary macroadenoma presenting with visual complaints

- Patients undergoing both transnasal and transcranial surgeries

- Patients whose tumour was totally removed or whose optic apparatus was adequately

decompressed

Exclusion Criteria

- Age less than 18 years

- Patients unwilling to participate in the study

- Patients with a history of intraocular surgery or laser surgery

- Patients who had a residual tumour on postoperative CT scans were excluded from the

study

- Other tumours causing compression of the chiasm or optic neuropathy (including

glaucoma) were excluded from the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean values of pre-operative visual acuity, along with RNFL and GCLT thickness using OCTTimepoint: Time point 1: time of diagnosis
Secondary Outcome Measures
NameTimeMethod
Post operative visual field improvement with change in thickness of RNFL & GCLTimepoint: 6 months from the date of surgery
© Copyright 2025. All Rights Reserved by MedPath